Mayo Clinic has launched a new biomanufacturing strategy that seeks to develop next-generation biotherapeutics that go beyond standard pharmaceuticals and deliver new cures for rare and complex conditions.
Category Archives: AZBio News
Study Shows Vaccine Protects Dogs Against Valley Fever
A team led by researchers at the University of Arizona Valley Fever Center for Excellence successfully tested a Valley fever vaccine for dogs, with two doses providing high levels of protection against the fungal disease.Continue reading
Researchers Develop Tools to Listen, Talk to Plants with $25M from NSF
Through a newly established NSF Science and Technology Center, University of Arizona researchers will use digital tools to communicate with plants and develop new crops to support sustainable agriculture.Continue reading
Humabiologics partners with Funakoshi to distribute human biomaterials in Japan
Humabiologics products are now available to researchers in Japan for use in regenerative medicine translational research, cell therapy, bioprinting, tissue & disease modeling, and drug screening applications.Continue reading
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
FDA Press Release: October 29, 2021 – Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.Continue reading
UArizona Health Sciences Researchers Weaponizing Copper as Potential Antibiotic
Researchers identified a compound that acts as a Trojan horse for copper, effectively killing pathogens that cause some upper respiratory infections.Continue reading
leanRAQA releases new Business Market Assessment Tool for Life Science Innovators
The Business Market Assessment tool to helps you understand the initial investment and recurring regulatory compliance costs you’ll face. The guide walks you through the revenue vs cost modeling calculations to help you judge the market viability of your product and see if a specific market makes sense.
Arizona’s Launch of the NAM Pharma Manufacturing Report
Learn about the biopharmaceutical industry’s footprint in the state of Arizona as we discuss the National Association of Manufacturers’ report:
Ensuring a Health Future: The Impact and Importance of Pharmaceutical Manufacturing.
Speakers:
Shawn DuBravac, PhD, CFA, President, Aviro Institute and New York Times Best Selling Author
Garrick Taylor, EVP, Arizona Chamber of Commerce & Industry
Moderator: Joan Koerber-Walker, president & CEO, Arizona Bioindustry Association (AZBio)
Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
For Immediate Release:
October 20, 2021
Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:Continue reading
Castle Biosciences to Acquire Cernostics
Fuels mid- and long-term growth with TissueCypher® platform enabling GI franchise
Acquisition will expand Castle’s estimated U.S. TAM by approximately $1 billionContinue reading